|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 14/705 | |||
| A61K 39/395 | |||
| G01N 33/50 | |||
| C12N 5/10 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2535355 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12178780.8 |
| Date of filing the European patent application | 2006-03-23 | |
| (97) | Date of publication of the European application | 2012-12-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 200500429 | 2005-03-23 | DK | |
| 667579 P | 2005-04-01 | US | |
| 696163 P | 2005-07-01 | US | |
| 728561 P | 2005-10-20 | US |
| (72) |
Graus, Yvo, NL
Parren, Paul, NL
van de Winkel, Jan, NL
de Weers, Michel, NL
Oprins, Judith, NL
van Vugt, Martine, NL
|
| (73) |
Genmab A/S,
Kalvebod Brygge 43, 1560 Copenhagen V,
DK
|
| (54) | Antibodies against CD38 for treatment of multiple myeloma |
| Antibodies against CD38 for treatment of multiple myeloma |